262 related articles for article (PubMed ID: 28424165)
1. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA
Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165
[TBL] [Abstract][Full Text] [Related]
2. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.
Poulard C; Kim HN; Fang M; Kruth K; Gagnieux C; Gerke DS; Bhojwani D; Kim YM; Kampmann M; Stallcup MR; Pufall MA
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3052-3061. PubMed ID: 30733284
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.
Schwartz JR; Sarvaiya PJ; Vedeckis WV
Mol Cell Endocrinol; 2010 May; 320(1-2):76-86. PubMed ID: 20170710
[TBL] [Abstract][Full Text] [Related]
4. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in glucocorticoid‑resistant B‑cell precursor acute lymphoblastic leukemia.
Sakurai N; Komada Y; Hanaki R; Morimoto M; Ito T; Nakato D; Hirayama M
Oncol Rep; 2019 Aug; 42(2):708-716. PubMed ID: 31233193
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
[TBL] [Abstract][Full Text] [Related]
7. MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.
Polak A; Kiliszek P; Sewastianik T; Szydłowski M; Jabłońska E; Białopiotrowicz E; Górniak P; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Nowis D; Gołąb J; Giebel S; Lech-Marańda E; Warzocha K; Juszczyński P
PLoS One; 2016; 11(5):e0155893. PubMed ID: 27196001
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell-type acute lymphoblastic leukemia.
Sarang Z; Gyurina K; Scholtz B; Kiss C; Szegedi I
Eur J Haematol; 2016 Nov; 97(5):453-460. PubMed ID: 26947147
[TBL] [Abstract][Full Text] [Related]
9. Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death.
Poulard C; Baulu E; Lee BH; Pufall MA; Stallcup MR
Cell Death Dis; 2018 Oct; 9(10):1038. PubMed ID: 30305606
[TBL] [Abstract][Full Text] [Related]
10. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia.
Sarno J; Domizi P; Liu Y; Merchant M; Pedersen CB; Jedoui D; Jager A; Nolan GP; Gaipa G; Bendall SC; Bava FA; Davis KL
Nat Commun; 2023 May; 14(1):2935. PubMed ID: 37217509
[TBL] [Abstract][Full Text] [Related]
12. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract][Full Text] [Related]
13. A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells.
Geng CD; Vedeckis WV
Mol Endocrinol; 2011 Jan; 25(1):44-57. PubMed ID: 21084380
[TBL] [Abstract][Full Text] [Related]
14. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
[TBL] [Abstract][Full Text] [Related]
16. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
[TBL] [Abstract][Full Text] [Related]
18. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
[TBL] [Abstract][Full Text] [Related]
19. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
Nicholson L; Hall AG; Redfern CP; Irving J
Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
[TBL] [Abstract][Full Text] [Related]
20. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]